{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:28:12Z","timestamp":1787509692007,"version":"build-2736575974"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.587769","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:12:16Z","timestamp":1603757536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Yuto","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Pecori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and Paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00515","article-title":"Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging","volume":"9","author":"Alrezk","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cancers11101505","article-title":"Current Management of Pheochromocytoma\/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine","volume":"11","author":"N\u00f6lting","year":"2019","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"key":"B5","volume-title":"Endocrine Tumor","year":"2017"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-011-9545-3","article-title":"Pheochromocytomas and paragangliomas: assessment of malignant potential","volume":"40","author":"Korevaar","year":"2011","journal-title":"Endocrine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23297","article-title":"Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades","volume":"107","author":"Goffredo","year":"2013","journal-title":"J Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/132.8.2345S","article-title":"Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk","volume":"132","author":"Ziegler","year":"2002","journal-title":"J Nutr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4158\/EP15725.OR","article-title":"Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma\/ paraganglioma: an National Institutes of Health study","volume":"22","author":"Turkova","year":"2016","journal-title":"Endocr Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000476","article-title":"Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management","volume":"26","author":"Hamidi","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/81551","article-title":"M\u00fcller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Bayley","year":"2010","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9479-2","article-title":"Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA","volume":"28","author":"Suh","year":"2017","journal-title":"Endocr Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.10.25","article-title":"Pheochromocytoma\/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options","volume":"9","author":"Antonio","year":"2020","journal-title":"Gland Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00b4e","year":"2013","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIFalpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.08.023","article-title":"HIF-2alpha: Achilles\u2019 heel of pseudohypoxic subtype paraganglioma and other related conditions","volume":"86","author":"Tella","year":"2017","journal-title":"Eur J Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12885-019-5813-z","article-title":"Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations","volume":"19","author":"Smestad","year":"2019","journal-title":"BMC Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1301302","article-title":"An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes","volume":"44","author":"Gimenez-Roqueplo","year":"2012","journal-title":"Horm Metab Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds374","article-title":"Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma","volume":"21","author":"Burnichon","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Qin","year":"2010","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0139","article-title":"Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma","volume":"25","author":"Job","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0068-7","article-title":"Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients","volume":"20","author":"Calsina","year":"2018","journal-title":"Genet Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline Mutations in the Mitochondrial 2-Oxoglutarate\/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas","volume":"78","author":"Buffet","year":"2018","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.04.010","article-title":"Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006795","article-title":"Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners","volume":"294","author":"Sandoval","year":"2019","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0003-y","article-title":"Gain-of-function mutations in DNMT3A in patients with paraganglioma","volume":"20","author":"Remacha","year":"2018","journal-title":"Genet Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas","volume":"23","author":"Remacha","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-008-0553-1","article-title":"Germline mutation of the KIF1Bb gene on 1p36 in a family with neural and nonneural tumors","volume":"124","author":"Yeh","year":"2008","journal-title":"Hum Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2016.12.007","article-title":"Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma\/paraganglioma: A clinicopathological correlations","volume":"102","author":"Pillai","year":"2017","journal-title":"Exp Mol Pathol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12885-018-4127-x","article-title":"A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2 V617F positive polycythemia vera: a case report","volume":"18","author":"Pang","year":"2018","journal-title":"BMC Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12920-018-0327-0","article-title":"Exome analysis of carotid body tumor","volume":"11","author":"Snezhkina","year":"2018","journal-title":"BMC Med Genomics"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-017-4320-0","article-title":"Activating FGFR1 Mutations in Sporadic Pheochromocytomas","volume":"42","author":"Welander","year":"2018","journal-title":"World J Surg"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29957","article-title":"Malignant pheochromocytomas\/paragangliomas harbor mutations in transport and cell adhesion genes","volume":"138","author":"Wilz\u00e9n","year":"2016","journal-title":"Int J Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1008803","DOI":"10.1371\/journal.pgen.1008803","article-title":"MYO5B mutations in pheochromocytoma\/paraganglioma promote cancer progression","volume":"16","author":"Tomi\u0107","year":"2020","journal-title":"PloS Genet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"Juhlin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezz115","article-title":"Clinicopathological, immunophenotypic and genetic studies of mediastinal paragangliomas","volume":"56","author":"Hsu","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0429","article-title":"Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia","volume":"21","author":"Papathomas","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ERC-17-0306","article-title":"TERT structural rearrangements in metastatic pheochromocytomas","volume":"25","author":"Dwight","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0016","article-title":"The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr Related Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-019-09594-1","article-title":". Malignant Intrarenal\/Renal Pelvis Paraganglioma with Co-Occurring SDHB and ATRX Mutations","volume":"30","author":"Irwin","year":"2019","journal-title":"Endocr Pathol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1617-1","article-title":"Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations","volume":"61","author":"Zhang","year":"2018","journal-title":"Endocrine"},{"key":"B60","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2245","article-title":"Mutations of the Metabolic Genes IDH1, IDH2, and SDHAF2 Are Not Major Determinants of the Pseudohypoxic Phenotype of Sporadic Pheochromocytomas and Paragangliomas","volume":"95","author":"Yao","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","article-title":"The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas","volume":"4","author":"Favier","year":"2009","journal-title":"PloS One"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0398","article-title":"Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma","volume":"21","author":"Vicha","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0340","article-title":"Energy and metabolic alterations in predisposition to pheochromocytomas and paragangliomas: the so-called Warburg (and more) effect, 15 years on","volume":"22","author":"Neumann","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.15698\/cst2020.06.221","article-title":"Mitochondria in cancer","volume":"4","author":"Grasso","year":"2020","journal-title":"Cell Stress"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.137034","article-title":"Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma","volume":"55","author":"van Berkel","year":"2014","journal-title":"J Nucl Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.216796","article-title":"Metabolic Subtyping of Pheochromocytoma and Paraganglioma by (18)F-FDG Pharmacokinetics Using Dynamic PET\/CT Scanning","volume":"60","author":"van Berkel","year":"2019","journal-title":"J Nucl Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2174\/156652409789105570","article-title":"Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation","volume":"9","author":"Katoh","year":"2009","journal-title":"Curr Mol Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-12-394622-5.00008-0","article-title":"Sonic Hedgehog regulates Wnt activity during neural circuit formation","volume":"88","author":"Wilson","year":"2012","journal-title":"Vitam Horm"},{"key":"B71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuroscience.2013.08.055","article-title":"The control of precerebellar neuron migration by RNA-binding protein Csde1","volume":"253","author":"Kobayashi","year":"2013","journal-title":"Neuroscience"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/bies.200900122","article-title":"Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression","volume":"32","author":"Mihailovich","year":"2010","journal-title":"Bioessays"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210068","article-title":"Unr. A cytoplasmic RNA-binding protein with cold-shock domains, is involved in control of apoptosis in ES and HuH7 cells","volume":"26","author":"Dormoy-Raclet","year":"2007","journal-title":"Oncogene"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/stem.712","article-title":"The RNA-binding protein Unr prevents mouse embryonic stem cells differentiation toward the primitive endoderm lineage","volume":"29","author":"Elatmani","year":"2011","journal-title":"Stem Cells"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/367380a0","article-title":"The c ret receptor tyrosine kinase gene is required for the development of the kidney and enteric nervous system","volume":"367","author":"Schuchardt","year":"1994","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.3.1613","article-title":"Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations","volume":"3","author":"Asai","year":"1995","journal-title":"Mol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN 2A","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0435","article-title":"HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES. Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop","volume":"27","author":"Dahia","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms A Clinicopathologic and Immunophenotypic Study of 100 Cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0494","article-title":"Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B81","article-title":"The systems of metastatic potential prediction in pheochromocytoma and paraganglioma","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0187398","DOI":"10.1371\/journal.pone.0187398","article-title":"Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma","volume":"12","author":"Koh","year":"2017","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.05.001","article-title":"A clinical prediction model to estimate the metastatic potential of pheochromocytoma\/paraganglioma: ASES score","volume":"164","author":"Cho","year":"2018","journal-title":"Surgery"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02553-5","article-title":"COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas\/paragangliomas","volume":"474","author":"Pierre","year":"2019","journal-title":"Virch Archiv"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-018-1679-9","article-title":"Juhlin CC. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms","volume":"403","author":"Stenman","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.02.019","article-title":"Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas","volume":"68","author":"Gao","year":"2006","journal-title":"Urology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"EC01","DOI":"10.7860\/JCDR\/2016\/20565.8419","article-title":"Risk Stratification in Paragangliomas with PASS (Pheochromocytoma of the Adrenal Gland Scaled Score) and Immunohistochemical Markers","volume":"10","author":"Kulkarni","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen","year":"2009","journal-title":"Lancet Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12022-013-9269-4","article-title":"Usefulness of Negative and Weak\u2013Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas","volume":"24","author":"Castelblanco","year":"2013","journal-title":"Endocr Pathol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09632-3","article-title":"Images in Endocrine Pathology: Progressive Loss of Sustentacular Cells in a Case of Recurrent Jugulotympanic Paraganglioma over a Span of 5 years","volume":"31","author":"Zhou","year":"2020","journal-title":"Endocr Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/jcm7090242","article-title":"Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine","volume":"7","author":"Kimura","year":"2018","journal-title":"J Clin Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-14-0756","article-title":"Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma","volume":"172","author":"Sue","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-018-9544-5","article-title":"Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma","volume":"29","author":"Konosu-Fukaya","year":"2018","journal-title":"Endocr Pathol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"4150735","DOI":"10.1155\/2020\/4150735","article-title":"The Expression of Snail, Galectin-3, and IGF1R in the Differential Diagnosis of Benign and Malignant Pheochromocytoma and Paraganglioma","volume":"27","author":"Deng","year":"2020","journal-title":"BioMed Res Int"},{"key":"B96","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.humpath.2018.11.020","article-title":"Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas","volume":"86","author":"Leijon","year":"2019","journal-title":"Hum Pathol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.10.041","article-title":"PD-L1 expression and association with malignant behavior in pheochromocytomas\/paragangliomas","volume":"86","author":"Guo","year":"2019","journal-title":"Hum Pathol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e1358332","DOI":"10.1080\/2162402X.2017.1358332","article-title":"Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior","volume":"6","author":"Pinato","year":"2017","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.587769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:12:19Z","timestamp":1603757539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.587769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":98,"alternative-id":["10.3389\/fendo.2020.587769"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.587769","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"article-number":"587769"}}